Trump Warns Pharma Firms of 5-8% Extra Tariffs Ahead of October Drug Pricing Deadline We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
CDSCO Panel Directs Malik Lifesciences to Revise Phase III Trial Protocol for Tamsulosin, Dutasteride, Tadalafil FDC We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
MSN Lab gets CDSCO panel nod for Phase IV CT of Tofacitinib Tablets 10 mg We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
SEC Recommends Phase III Trial of MSN Labs’ Vibegron Against Mirabegron in Overactive Bladder We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Not All Combipacks Are New Drugs: CDSCO Defines Approval Rules for Lyophilized Injections We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Bombay HC Quashes Maharashtra FDA, CDSCO Stop-Production Orders Against 2 Pharma Firms We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
CDSCO Panel Directs Intas Pharma to Revise Phase I/III Pembrolizumab Trial Protocol We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
MSN Lab gets CDSCO panel nod for Phase IV CT of Tofacitinib Oral Solution We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
CDSCO Panel Approves Novo Medi Sciences’ Phase III Booster Study of PCV13 Pneumococcal Vaccine in Infants We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
CDSCO Panel Asks Takeda to Submit Full Phase III Data on Dengue Tetravalent Vaccine We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link